Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mendelics | RCV002247327 | SCV002518412 | uncertain significance | not specified | 2022-05-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000086260 | SCV003444650 | pathogenic | not provided | 2023-07-07 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 11421). This premature translational stop signal has been observed in individual(s) with congenital stationary night blindness (PMID: 11062471). It has also been observed to segregate with disease in related individuals. This variant is present in population databases (rs62637037, gnomAD 0.008%). This sequence change creates a premature translational stop signal (p.Trp350*) in the NYX gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 132 amino acid(s) of the NYX protein. |
OMIM | RCV000012174 | SCV000032408 | pathogenic | Congenital stationary night blindness 1A | 2000-11-01 | no assertion criteria provided | literature only | |
Retina International | RCV000086260 | SCV000118406 | not provided | not provided | no assertion provided | not provided |